Structure−Activity Relation of Human β-Defensin 3: Influence of Disulfide Bonds and Cysteine Substitution on Antimicrobial Activity and Cytotoxicity
- 24 June 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 44 (28), 9804-9816
- https://doi.org/10.1021/bi050272k
Abstract
Human β-defensins form a group of cysteine-rich antimicrobial peptides which have been found in epithelial tissue and, more recently, in the male genital tract. They play a role in the defense against microbial pathogens in innate immunity and display additional chemotactic functions in the adaptive immune system. An important characteristic of antimicrobial peptides is that they also exhibit toxic potential on eukaryotic cells. Very little is known about the structure dependence of antimicrobial and cytotoxic effects. We investigated human β-defensin 3 (hBD-3), a potent broad-spectrum antimicrobial effector peptide, regarding the influence of structural parameters on the antimicrobial and cytotoxic activity. We have established a structure−activity relation of the hBD-3 using synthetic derivatives differing in length, charge, disulfide connectivity, and overall hydrophobicity. The antimicrobial activity of the peptides was compared to the cyctotoxic effects on monocytic THP-1 cells and the hemolytic activity on human erythrocytes. We found that it is not important for antimicrobial and cytotoxic activity whether and how cysteine residues are arranged to form disulfide bonds. Substitution of half-cystinyl residues by tryptophan resulted in increased activities, while other substitutions did not change activity. Correlation of activities with the structural changes demonstrates that the activity on eukaryotic cells appears to depend strongly on the overall hydrophobicity. In contrast, the antimicrobial potency of hBD-3 peptides is determined by the distribution of positively charged amino acid residues and hydrophobic side chains. The results facilitate the understanding of β-defensin interaction with different cell types and guide the design of antimicrobially active peptides.Keywords
This publication has 12 references indexed in Scilit:
- Engineering disulfide bonds of the novel human β‐defensins hBD‐27 and hBD‐28: Differences in disulfide formation and biological activity among human β‐defensinsPeptide Science, 2004
- Mechanisms of Antimicrobial Peptide Action and ResistancePharmacological Reviews, 2003
- The Structure of Human β-Defensin-1Journal of Biological Chemistry, 2001
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001
- Development of protegrins for the treatment and prevention of oral mucositis: Structure-activity relationships of synthetic protegrin analoguesBiopolymers, 2000
- A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptidesFEBS Letters, 1999
- Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.Journal of Clinical Investigation, 1998
- Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.Journal of Clinical Investigation, 1998
- A peptide antibiotic from human skinNature, 1997
- hBD‐1: a novel β‐defensin from human plasmaFEBS Letters, 1995